Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
53512-U
Ascentis® Express 90Å C8 (2.7 μm) HPLC Columns
L × I.D. 5 mm × 4.6 mm, HPLC Guard Cartridge, pkg of 3 ea
Synonym(s):
Core-shell (SPP) Fused Core C8 HPLC column
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 3 ea | Available to ship TODAYfromMILWAUKEE | $722.00 |
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
5 mm × 4.6 mm
Particle size:
2.7 μm
Matrix active group:
C8 (octyl) phase
Pore size:
90 Å
Matrix:
superficially porous particle
$722.00
Available to ship TODAYDetails
Subscriptions are currently unavailable.
Ships Every 4 weeks
Product Name
Ascentis® Express C8, 2.7 μm Guard Cartridge, 2.7 μm particle size, L × I.D. 5 mm × 4.6 mm, pkg of 3 ea
material
stainless steel column
Quality Level
agency
suitable for USP L7
product line
Ascentis®
feature
endcapped
packaging
pkg of 3 ea
technique(s)
HPLC: suitable, LC/MS: suitable
L × I.D.
5 mm × 4.6 mm
surface area
135 m2/g
matrix
superficially porous particle
matrix active group
C8 (octyl) phase
particle size
2.7 μm
pore size
90 Å
operating pH
2-9
application(s)
food and beverages
separation technique
reversed phase
General description
Ascentis Express Guard Columns provide physical (filtration) and chemical protection for costly analytical columns without compromising the very high performance of Ascentis Express columns. These Ascentis Express guard columns are capable of continuous use at pressures up to 9000 psi (600 bar) with only hand-tightening. Guard cartridges are easily replaced without removing the guard column holder from the flow path. The cartridges are packed with Ascentis Express Fused-Core® particles. Order guard column holder separately.
Legal Information
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Fused-Core is a registered trademark of Advanced Materials Technology, Inc.
1 of 1
This Item | |||
|---|---|---|---|
| separation technique reversed phase | separation technique reversed phase | separation technique reversed phase | separation technique reversed phase |
| particle size 2.7 μm | particle size 2.7 μm | particle size 5 μm | particle size 2.7 μm |
| matrix active group C8 (octyl) phase | matrix active group C8 (octyl) phase | matrix active group C8 (octyl) phase | matrix active group C8 (octyl) phase |
| L × I.D. 5 mm × 4.6 mm | L × I.D. 5 mm × 2.1 mm | L × I.D. 5 mm × 2.1 mm | L × I.D. 5 mm × 3 mm |
| pore size 90 Å | pore size 90 Å | pore size 90 Å | pore size 90 Å |
| matrix superficially porous particle | matrix superficially porous particle | matrix superficially porous particle | matrix superficially porous particle |
Still not finding the right product?
Explore all of our products under Ascentis® Express C8, 2.7 μm Guard Cartridge
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
When a C18 doesn′t give the desired separation, or your sample contains compounds that are known to be difficult to retain or resolve on a C18, consider changing to an Ascentis® Express C8 column.
Ugandar Reddy Inugala et al.
Journal of chromatographic science, 51(5), 453-459 (2012-10-13)
This paper describes the development of a rapid, novel, stability-indicating gradient reversed-phase high-performance liquid chromatographic method and associated system suitability parameters for the analysis of naproxcinod in the presence of its related substances and degradents using a quality-by-design approach. All
Sreenivasa Rao Chitturi et al.
Journal of pharmaceutical and biomedical analysis, 55(1), 31-47 (2011-02-15)
This paper proposes a simple and selective RP-HPLC method for the determination of process impurities and degradation products (degradants) of atazanavir sulfate (ATV) drug substance. Chromatographic separation was achieved on Ascentis(®) Express C8, (150mm×4.6mm, 2.7μm) column thermostated at 30°C under
Luigi Silvestro et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(30), 3134-3142 (2010-10-20)
Quantitative methods using LC-MS/MS allow achievement of adequate sensitivity for pharmacokinetic studies with clopidogrel; three such methods, with LLOQs as low as 5 pg/mL, were developed and fully validated according to the well established FDA 2001 guidelines. The chromatographic separations
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 53512-U | 04061838531223 |
-
What is the Department of Transportation shipping information for this product?
1 answer-
Helpful?
-